NFKB1 and metabolic dysfunction-associated steatohepatitis: Once activated, these receptors trigger the NF-κB pathway, leading to oxidative stress in hepatocytes by promoting the release of pro-inflammatory cytokines, such as TNF-α, from Kupffer cells, which may lead to liver tissue damage and facilitate the progression of NASH [15].